-
-
-
-
-
-
-
H.C. Wainwright on Viking Therapeutic (VKTX): 'We expect the Phase 3 program to continue building on this foundation'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Prices 17.24M Share Offering at $14.50/sh
-
-
-
-
-
-
-
Viking Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
-
-
-
-
-
-
-
Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
-
-
-
-
-
-
Viking Therapeutics to Present at Upcoming Investor Conferences
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

